Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Acute Myeloid Leukemia
Interventions: Lenalidomide; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cachexia
Interventions: Deuterated Water, Testosterone enanthate, Placebo to match testosterone enanthate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 60 Years to 75 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Acute Migraine
Interventions: Acetaminophen 250 mg and Aspirin 250 mg, Placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 19
States / cities: Birmingham, Alabama • Anaheim, California • San Francisco, California + 16 more

Conditions: Tobacco Dependence
Interventions: nicotine lozenges, tobacco-free snuff; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Rochester, Minnesota • Eugene, Oregon

Conditions: Diabetes Mellitus
Interventions: Pamphlet, Video; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Aurora, Colorado • Chicago, Illinois

Conditions: Down Syndrome
Interventions: Promoting Health through Parent Empowerment and the Activation of Routines, Enhanced Usual Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Months and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Colon Cancer, Rectum Cancer
Interventions: Cetuximab, Irinotecan; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Psychotherapy
Interventions: Therapy Session; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Tumor
Interventions: belinostat, 5-Fluorouracil (5-FU); Drug
Lead sponsor: Valerio Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 3
States / cities: Scottsdale, Arizona • Omaha, Nebraska • Portsmouth, New Hampshire

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Saint Thomas Health; Other
Eligibility: 60 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Alzheimer Disease, Dementia, Caregiver Burden, Quality of Life, Activities of Daily Living
Interventions: The MapHabit system, Dementia educational videos; Device
Lead sponsor: MapHabit, Inc.; Industry
Eligibility: Not listed
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Gamma Tocopherol Serum Levels
Interventions: Gamma tocopherol; Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BMS-214662, trastuzumab, pharmacological study; Drug · Biological · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoporosis
Interventions: Zoledronic Acid; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 65 Years to 89 Years · Female only
Enrollment: 7,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 59
States / cities: Birmingham, Alabama • Paradise Valley, Arizona • Tucson, Arizona + 50 more

Conditions: Hodgkin's Disease, Lymphoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteopenia, Osteoporosis
Interventions: Pamidronate, Calcium and vitamin D; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 1 Year to 20 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Tic Disorder, Childhood, Comorbidities and Coexisting Conditions
Interventions: Combination of Comprehensive Behavioral Intervention for Tics (CBIT) and Evidence-based interventions for co-occurring diagnoses (i.e., Cognitive Behavioral Therapy, Behavioral Parent Training); Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Depressive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Palo Alto, California • Providence, Rhode Island

Conditions: Delayed Graft Function
Interventions: Not listed
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 82 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Shock, Critical Illness
Interventions: Cheetah NICOM; Device
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Menopause
Interventions: Estradiol vaginal ring, Placebo vaginal ring; Drug · Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 40 Years to 89 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Spinal Cord Injury
Interventions: Surgery, IRS-8; Procedure · Device
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2016
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Dental Caries
Interventions: Test Dentifrice, Reference Dentifrice, Negative Control Dentifrice; Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Abdominal Abscess, Pelvic Abscess
Interventions: Alteplase, saline; Drug · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Honolulu, Hawaii

Search by objective public record fields.

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine

Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction

Encouraging Patient-Centered Communication in Clinical Video Telehealth Visits

Promoting Health Through Parent Empowerment and the Activation of Routines (PrO-PEAR)

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

Increasing Access to Evidence-Based Care in Integrated Behavioral Health

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

CABG REVEAL: Atrial Fibrillation After Coronary Artery Bypass Graft

Assistive Technology and Reduced Caregiver Burden

Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects

BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors

HORIZON-PFT: Pivotal Fracture Trial

Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

Improving Symptom Trajectories of Tic Disorders and Co-occurring Diagnoses: The Role of Integrative Intensive Intervention

Imaging to Improve Brain Stimulation

Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Estrogen and the Urogenital Microbiome in GSM

Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries

A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries

Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses